ASCO notebook

June 2013
Medical Device Daily;6/3/2013, Vol. 17 Issue 106, p4
The article reports that medical technologies and services provider GE Healthcare has announced its intention to commercialize MultiOmyx, a pathology platform, using proprietary methodology to analyze multiple proteins at a single-cell level.


Related Articles

  • Product Briefs.  // Medical Device Daily;3/25/2013, Vol. 17 Issue 57, p9 

    This section offers news briefs concerning the medical device sector, as of March 2013. A U.S. Food and Drug Administration (FDA) approval was given to AdreView, a molecular imaging agent that links nerve function in the heart to a patient's mortality risk, developed by GE Healthcare. An FDA...

  • Gamma Imaging and Dense Breasts. Hardy, Kathy // Radiology Today;Oct2015, Vol. 16 Issue 10, p16 

    No abstract available.

  • Calling in reinforcements: Women with dense breasts get help from ultrasound, molecular imaging, and MRI. Massat, Mary Beth // Applied Radiology;Sep2014, Vol. 43 Issue 9, p34 

    No abstract available.

  • Breast exam while you wait?  // Mayo Clinic Health Letter;2013 Supplement, p6 

    The article discusses the Mayo Clinic Nuclear Cardiology Laboratory which offers dual services of cardiac nuclear scan as well as molecular breast imaging test that identifies tumors even in deep breast tissue.

  • Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data. Ren, Hai-Yong; Sun, Ling-Ling; Li, Heng-Yuan; Ye, Zhao-Ming // BioMed Research International;11/4/2015, Vol. 2015, p1 

    Background. Serum alkaline phosphatase (SALP) is commonly elevated in osteosarcoma patients. A number of studies have investigated the prognostic role of SALP level in patients with osteosarcoma but yielded inconsistent results. Method. Systematic computerized searches were performed in PubMed,...

  • Molecular Imaging Probes for Diagnosis and Therapy Evaluation of Breast Cancer. Qingqing Meng; Zheng Li // International Journal of Biomedical Imaging;2013, p1 

    Breast cancer is a major cause of cancer death in women where early detection and accurate assessment of therapy response can improve clinical outcomes. Molecular imaging, which includes PET, SPECT, MRI, and optical modalities, provides noninvasive means of detecting biological processes and...

  • GETTING SPECIFIC. Hardy, Kathy // Radiology Today;Feb2012, Vol. 13 Issue 2, p30 

    The article presents information on studies related to breast specific gamma imaging (BSGI) and its advancement over Mammography and ultrasound in studying breast cancer. Molecular breast imaging images the metabolic activity of breast lesions by utilizing radiotracer contrast and a...

  • World's first intra-operative molecular imaging system LightPath obtains CE Mark Approval.  // Operating Theatre Journal;Nov2015, Issue 302, p6 

    No abstract available.

  • Delphinus gains 501(k) for breast ultrasound tomography. Pedersen, Amanda // Medical Device Daily;1/8/2014, Vol. 18 Issue 5, p1 

    The article reports that SoftVue whole breast ultrasound tomography system from Delphinus Medical Technologies Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for diagnostic breast imaging. The company is said to be the first to receive FDA clearance for breast...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics